Expert CRO Harmony Clinical Research adopts BSI’s eTMF to scale up its clinical trial operations
BSI Life Sciences announces Harmony Clinical Research (HarmonyCR) as the latest client to adopt its cloud-based electron…
BSI Life Sciences announces Harmony Clinical Research (HarmonyCR) as the latest client to adopt its cloud-based electron…
VG901 is the first and only clinical-stage therapy designed to deliver a functional CNGA1 gene to retinal photoceptor t…
Two of six patients receiving NOX-A12 in combination with bevacizumab and radiotherapy exceeded 24-month survival si…
Laife Reply, ein Unternehmen der Reply Gruppe, das sich zum Ziel gesetzt hat, mit Hilfe von Künstlicher Intelligenz (KI)…
Tyenne® is the first tocilizumab biosimilar by Fresenius Kabi, an operating company of Fresenius, with an intravenous an…
Financial Highlights Direct MagnetOs sales rose by 155% to CHF 13.9 million in Q1 2024 from CHF 5.4 million in Q1 2023…
Wie jedes Jahr im April trifft sich die gesamte Health-IT-Branche vom 09. bis 11. April in Berlin auf der DMEA, Europas…
Krebsfrei statt dreimonatiger Lebenserwartung – Wissenschaftler und Wissenschaftlerinnen von ASC Oncology haben mit Hilf…
Interim clinical data update on ACTengine® IMA203 GEN1 (PRAME) in melanoma at RP2D in November 2023: 50% confirmed objec…
MHH spin-off Cardior will be taken over for up to EUR 1.025 billion including an upfront payment and additional paym…